A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals

International Journal of Technology Assessment in Health Care

Volumn 17, Issue 2, 2001, Pages 171-180

  Dranitsaris, George ^a   Spizzirri, Diana ^a   Pitre, Monique ^a   McGeer, Allison ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Antibiotics; Drug use evaluation; Evidence based guidelines; Pharmacist

Indexed keywords

CEFOTAXIME;

ADULT; ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEPHALOSPORINS; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; HOSPITALS, URBAN; HUMANS; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROSPECTIVE STUDIES;

EID: 0034978510     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300105033     Document Type: Review

References (17)

1. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings
2. Strategies to improve antibiotic use
3. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
4. Microbial resistance to drug therapy: A review
5. Formulary control of antimicrobial usage. What price freedom?
6. Antimicrobial misuse in patients with positive blood cultures
7. Antibiotic misuse in two clinical situations: Positive blood culture and administration of aminoglycosides
8. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals
9. Identification and assessment of prognostic factors
10. Antibiotic resistance in streptococci and enterococci. Where are we and where are we going?
11. Enterococci resistant to multiple antimicrobial agents, including vancomcyin. Establishment of endemicity in a university medical center
12. No magic bullets: A systematic review of 102 trials of interventions to improve professional practice
13. Risk factors for the spread of antibiotic-resistant bacteria
14. The Canadian Nosocomial Infection Surveillance Program: Results of the first 18 months of surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals
15. Improving the quality and economy of in-hospital prescribing: Getting more for less
16. Monitoring of antibiotic use in a primary and tertiary care hospital